Breakthrough for secure mobile services in Swedish

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Apr 21, 2015 at 2:15 AM

Breakthrough for secure mobile services in Swedish healthcare

Precise Biometrics smart card reader Tactivo™ has been approved for usage with Swedish national healthcare system Pascal, a prescription tool for dose packaged medicals used by nurses, doctors and midwives. The solution with Tactivo provides swift and secure access to the prescription tool Pascal from iPhone or iPad using SITHS-card login, an identification card for Swedish care professionals. Pascal has over 50 000 users within the municipalities and private careproviders for prescription of medicals distributed in dosage bags. ”The approval of Tactivo for mobile access to Pascal is a breakthrough for secure mobile services within Swedish healthcare and we are certain that more care systems will follow this development. There are many situations where mobile access to patient information can improve quality for both staff and patients, and at the same time protect confidentiality through two-factor authentication”, says Håkan Persson, CEO Precise Biometrics. The mobile solution with Tactivo makes it possible for care providers to reduce staff workload and implemement a more efficient way of working that provides staff with access to accurate and secure information, independent of location. "We have been waiting a long time to use Pascal on mobile devices in a secure fashion. Thanks to Tactivo it is now possible for our staff to be more effective in their work with the patients. We can increase our presence with the patients not having to return to the office to update patient files on medication. This solution also increases patient security as we always have access to accurate information”, says Lise-Lotte Carlsson, system administrator, Kungsbacka municipality. Beside iPhone, iPad and Tactivo, the solution consists of the access service Mobilt SITHS from Svensk e-identitet and the log-on application NetID from SecMaker. As part of the approval process, Nordic Medtest has evaluated that the solution follows security requirements for usage of patient data on mobile devices. Pascal is owned and administered by Inera, the Swedish county and regional e -health company. The system is scheduled to be deployed on April 24, when it will become accessible for all Pascal users. For more information about Pascal mobile access, please visit; http://precisebiometrics.com/smart-card -reader/healthcare-solutions/ About Tactivo Tactivo is a product portfolio of form-fitted smart card readers that provides convenient and secure access to restricted resources from mobile devices. Tactivo reduces workload for caregivers, increasing productivity, ensuring a more efficient way of working and allow staff to spend more time with patients. Tactivo is also available for Android. This press release contains information that Precise Biometrics is required to disclose pursuant to the Swedish Financial Instruments Trading Act (1991:980). The information was submitted for publication at 08.00 am on April 21st, 2015. iPhone and iPad are trademarks of Apple Inc., registered in the U.S. and other countries. iPad Air and iPad mini are trademarks of Apple Inc. FOR MORE INFORMATION, PLEASE CONTACT Håkan Persson, CEO, Precise Biometrics AB Tel. 46 46 31 11 05 or 46 734 35 11 05 E-mail hakan.persson@precisebiometrics.com ABOUT PRECISE BIOMETRICS Precise Biometrics is a market leading supplier of solutions for fingerprint recognition that guarantee the identity of people. With the highest level of competence in fingerprint biometrics, Precise Biometrics offers fast, precise and secure verification of a person's identity. The company´s products can be used for ID, company and bank cards, and for access to mobile solutions, computers and networks. Precise Biometrics delivers its solutions to companies and government agencies all over the world, and the Company's technology is licensed to almost 160 million users. For further information go to www.precisebiometrics.com

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Uber Data Breach: Class Action Investigation Begins

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Motphys Unleashes MotrixSim 1.0, Aiming at Simulation Dominance

Motphys Breaks into the Global Simulation Scene The tech world just got slammed with what might be a seismic shift: Motphys, a bold outfit hailing from China, has dropped its brand-new, homegrown simulation engine, MotrixSim 1.0. It's causing quite the stir, unveiling at the Conference on Robot Learning 2026 (CoRL) and throwing down the gauntlet to Western titans like...

Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

Manhattan Associates Faces Investigation by KSF Law Firm

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

MV Transportation Celebrates Leadership Nomination for FTA

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

BETR's Slide: Investors Face Big Losses, Leadership Shift

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

LaserAway Expands to 244 Clinics Over 20 Years

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Webull Faces Class Action: Key Details for Investors

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

CARsgen's CAR-T Breakthrough on China's Insurance List

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...